Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Table of Contents

March-April 2024; Volume 21,Issue 2

Review

  • Open Access
    CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia
    ADAM NOPORA and ULRICH H. WEIDLE
    Cancer Genomics & Proteomics March 2024, 21 (2) 118-136; DOI: https://doi.org/10.21873/cgp.20434

Articles

  • Open Access
    Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma
    YOHEI OKUDA, TAIGO KATO, KAZUTOSHI FUJITA, HIROAKI FUSHIMI, HIROSHI MIYAMOTO, GEORGE J. NETTO and NORIO NONOMURA
    Cancer Genomics & Proteomics March 2024, 21 (2) 137-143; DOI: https://doi.org/10.21873/cgp.20435
  • Open Access
    Non-homologous End-joining Genotype, mRNA Expression, and DNA Repair Capacity in Childhood Acute Lymphocytic Leukemia
    CHAO-CHUN CHEN, WEN-SHIN CHANG, JEN-SHENG PEI, CHIEN-CHUNG KUO, CHUNG-HSING WANG, YUN-CHI WANG, PEI-CHEN HSU, JIE-LONG HE, JIAN GU, DA-TIAN BAU and CHIA-WEN TSAI
    Cancer Genomics & Proteomics March 2024, 21 (2) 144-157; DOI: https://doi.org/10.21873/cgp.20436
  • Open Access
    POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma
    DAIKI SHIMIZU, MIKU ISHIBASHI, TADAAKI YAMADA, YUKI TODA, SHIGEKUNI HOSOGI and EISHI ASHIHARA
    Cancer Genomics & Proteomics March 2024, 21 (2) 158-165; DOI: https://doi.org/10.21873/cgp.20437
  • Open Access
    CUL4A Ubiquitin Ligase Is an Independent Predictor of Overall Survival in Pancreatic Adenocarcinoma
    PANAGIOTIS TAVLAS, SOFIA NIKOU, CHRISTINA GERAMOUTSOU, PINELOPI BOSGANA, SPYRIDON CHAMPERIS TSANIRAS, MARIA MELACHRINOU, IOANNIS MAROULIS and VASILIKI BRAVOU
    Cancer Genomics & Proteomics March 2024, 21 (2) 166-177; DOI: https://doi.org/10.21873/cgp.20438
  • Open Access
    Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX Models
    HIDEYUKI KINOSHITA, SEIKO KINOSHITA, HIROTO KAMODA, YOKO HAGIWARA, SEIJI OHTORI and TSUKASA YONEMOTO
    Cancer Genomics & Proteomics March 2024, 21 (2) 178-185; DOI: https://doi.org/10.21873/cgp.20439
  • Open Access
    PRIM2: A Marker of MYC-driven Hyper-proliferation, Disease Progression, Tumor Aggressiveness and Poor Survival in Glioma Patients
    RONGHUI SUN, XIAODONG SHAO, FARHANA AKTER, KASHIF RAFIQ ZAHID, SHUN YAO, LIANTING MA and GUOZHENG XU
    Cancer Genomics & Proteomics March 2024, 21 (2) 186-202; DOI: https://doi.org/10.21873/cgp.20440
  • Open Access
    Impact of Tumor Grade Distribution on Genetic Alterations in Clear Cell Renal Cell Carcinoma and Prostate Cancer
    KOSUKE MIZUTANI, SEIJI SUGIYAMA, KOJI KAMEYAMA, SHINGO KAMEI, SHIGEAKI YOKOI, AKEMI MORIKAWA, MAKOTO TAKEUCHI, KENSAKU SEIKE, TORU YAMADA, HIDETOSHI EHARA, SEIYA SAWADA, KOUSEKI HIRADE, HIROHITO FURUTA, KENGO MATSUNAGA, TETSUYA YAMADA, IPPEI SAKAMOTO, YASUTAKA KATO, HIROSHI NISHIHARA, SATOSHI ISHIHARA and TAKASHI DEGUCHI
    Cancer Genomics & Proteomics March 2024, 21 (2) 203-212; DOI: https://doi.org/10.21873/cgp.20441
Back to top
PreviousNext

In this issue

Cancer Genomics - Proteomics: 21 (2)
Cancer Genomics & Proteomics
Vol. 21, Issue 2
March-April 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)

Issue highlights

  • CircRNAs as New Therapeutic Entities and Tools for Target Identification in Acute Myeloid Leukemia
  • Association of Androgen Receptor and PD-L1 Expression in Upper Urinary Tract Urothelial Carcinoma
  • Non-homologous End-joining Genotype, mRNA Expression, and DNA Repair Capacity in Childhood Acute Lymphocytic Leukemia
  • Thioredoxin Reductase Inhibitor Suppresses the Local Progression of Rhabdomyosarcoma With PDX Models
  • CUL4A Ubiquitin Ligase Is an Independent Predictor of Overall Survival in Pancreatic Adenocarcinoma
Sign up for alerts

Jump to

  • Review
  • Articles
  • Top Topics
  • Most Cited
  • Most Read
Loading
Breast Cancer Metastasis
Applications of Support Vector Machine (SVM) Learning in Cancer Genomics
Cancer-related Issues of CD147
Long Non-coding RNAs and their Role in Metastasis
The Multiple Roles of Exosomes in Metastasis
Screening for Epigenetically Masked Genes in Colorectal Cancer Using 5-Aza-2’-deoxycytidine, Microarray and Gene Expression Profile
Cancer & Genome Proteomics

© 2025 Cancer Genomics & Proteomics

Powered by HighWire